GEN and GNMSF Related Headlines
Go BackGEN and GNMSF Related Press Releases
Go Back- Genentech and Biogen Idec Have Filed for a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case
- Genmab Announces Financial Results for the First Quarter of 2013
- Genmab Announces Top-Line Phase II Results for Ofatumumab Combined With Bendamustine in Untreated and Relapsed Chronic Lymphocytic Leukemia
- Daratumumab Receives Breakthrough Therapy Designation From US Food and Drug Administration
- Arzerra First Quarter 2013 Net Sales Figures
- Passing of Genmab A/S' Annual General Meeting
- Genmab Announces Final US Court Judgment in Favor of Arzerra in Patent Infringement Lawsuit
- Daratumumab Granted Fast Track Designation From U.S. Food and Drug Administration
- Arzerra Receives Approval in Japan
